/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Mototsugu Shimokawa

Yamaguchi University(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

570

Papers

6.2K

Citations

39

h-index

168

i10-index

Mototsugu Shimokawa is an academic researcher from Yamaguchi University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 39, co-authored 485 publications.

ORCID: 0000-0001-8140-4565

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Cancer Immunotherapy and Biomarkers Colorectal Cancer Treatments and Studies Pancreatic and Hepatic Oncology Research

Papers by this author

works

Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study

2019 · Breast Cancer · 53 citations

https://doi.org/10.1007/s12282-019-01001-1

Yoichi Naito Yuichiro Kai Takashi Ishikawa Tomoyuki Fujita

Prognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma Patients

2019 · Annals of Surgical Oncology · 36 citations

https://doi.org/10.1245/s10434-019-07231-z

Shinkichi Takamori Kazuki Takada Koichi Azuma Tomoko Jogo

A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study

2022 · BMC Cancer · 30 citations

https://doi.org/10.1186/s12885-022-09385-8

Kazuki Takada Mototsugu Shimokawa Shinkichi Takamori Shinichiro Shimamatsu

Multicenter phase II study of SOX plus trastuzumab for patients with HER2+ metastatic or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS 1501B

2019 · Cancer Chemotherapy and Pharmacology · 27 citations

https://doi.org/10.1007/s00280-019-03991-3

Satoshi Yuki Katsunori Shinozaki Tomomi Kashiwada Tetsuya Kusumoto

Trifluridine/tipiracil plus bevacizumab as a first‐line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): A multicenter phase II trial

2020 · Cancer Medicine · 27 citations

https://doi.org/10.1002/cam4.3618

Eiji Oki Akitaka Makiyama Yuji Miyamoto Masahito Kotaka

Discontinuation of Nilotinib in Patients with Chronic Myeloid Leukemia Who Have Maintained Deep Molecular Responses for at Least 2 Years: A Multicenter Phase 2 Stop Nilotinib (Nilst) Trial

2016 · Blood · 26 citations

https://doi.org/10.1182/blood.v128.22.790.790

Norimitsu Kadowaki Tatsuya Kawaguchi Junya Kuroda Hirohisa Nakamae

Research topics

topics

Lung Cancer Treatments and Mutations

Lung Cancer Research Studies

Cancer Immunotherapy and Biomarkers

Colorectal Cancer Treatments and Studies

Pancreatic and Hepatic Oncology Research

Chat about Author

Papers

Chat

Click to start Chat